The Effectivity of Combination of Standard Interferon-alpha

被引:0
|
作者
Ozgunes, Nail [1 ]
Sargin, Fatma [1 ]
Yazici, Saadet [1 ]
Ceylan, Nuket [1 ]
Ucisik, Ayse Canan [1 ]
Ergen, Pinar [1 ]
Dogru, Arzu [1 ]
Aydin, Ozlem [1 ]
机构
[1] SB Goztepe Egitim & Arastirma Hastartesi, Infeks Elastaliklan & Klin Mikrobiyol Klin, Istanbul, Turkey
来源
关键词
Chronic hepatitis C; interferon alpha; pegylated interferon alpha; ribavirin;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
This study was done in order to evaluate the effectivity of combination therapy of standard interferon alpha (IFN-alpha) + ribavirin and pegylated IFN-alpha (PEG-IFN-alpha) + ribavirin in patients with chronic hepatitis C between 2003-2005 years in our clinic. Totally 52 patients were included in the study. In the combination treatment protocols, standard IFN-alpha 2 alpha or 2b plus ribavirin was given in 35 patients (group I) and PEG-IFN-a plus ribavirin in 17 patients (group II). Duration of treatment was 12 months. Rate of biochemical and virological responses at the end of the therapy and sustained response were 66.6%, 78.7%, 57.7% in group I and 71.4%, 85%, 66.7% in group II, respectively In conclusion, treatment protocols was effective in both groups and the rate of biochemical and virologic responses at the end of the therapy and sustained response were higher in group II than group I but the differences between groups were not significant. In according to the results of this study; PEG-IFN should be preferred to standard IFN-alpha.
引用
收藏
页码:61 / 64
页数:4
相关论文
共 50 条
  • [1] Standard interferon-alpha in combination with ribavirin for hepatitis C patients with advanced liver disease and thrombocytopenia
    Hofer, Harald
    Gurguta, Calin
    Bergholz, Ulrike
    Steindl-Munda, Petra
    Ferenci, Peter
    WIENER KLINISCHE WOCHENSCHRIFT, 2006, 118 (19-20) : 595 - 600
  • [2] INTERFERON-ALPHA IN COMBINATION WITH OTHER BIOLOGICS - THE SCIENTIFIC RATIONALE
    HERBERMAN, RB
    ERNSTOFF, MS
    KIRKWOOD, JM
    BRITISH JOURNAL OF HAEMATOLOGY, 1991, 79 : 78 - 80
  • [3] Combination of interferon-alpha and hydroxyurea in the treatment of idiopathic hypereosinophilic syndrome
    Demiroglu, H
    Dundar, S
    BRITISH JOURNAL OF HAEMATOLOGY, 1997, 97 (04) : 928 - 929
  • [4] In vitro immunomodulatory properties of gemcitabine alone and in combination with interferon-alpha
    Fritz, Jasmin
    Karakhanova, Svetlana
    Brecht, Ramona
    Nachtigall, Ines
    Werner, Jens
    Bazhin, Alexandr V.
    IMMUNOLOGY LETTERS, 2015, 168 (01) : 111 - 119
  • [5] INDUCTION OF INTERFERON-ALPHA BY INTERFERON-BETA, BUT NOT OF INTERFERON-BETA BY INTERFERON-ALPHA, IN THE MOUSE
    ASANO, M
    HAYASHI, M
    YOSHIDA, E
    KAWADE, Y
    IWAKURA, Y
    VIROLOGY, 1990, 176 (01) : 30 - 38
  • [6] INTERFERON-ALPHA IN LYMPHOMA
    ROHATINER, AZS
    BRITISH JOURNAL OF HAEMATOLOGY, 1991, 79 : 26 - 29
  • [7] NEUROTOXICITY OF INTERFERON-ALPHA
    MERIMSKY, O
    CHAITCHIK, S
    ANTI-CANCER DRUGS, 1992, 3 (06) : 567 - 570
  • [8] INTERFERON-ALPHA HYBRIDS
    HORISBERGER, MA
    DIMARCO, S
    PHARMACOLOGY & THERAPEUTICS, 1995, 66 (03) : 507 - 534
  • [9] IS INTERFERON-ALPHA ATHEROGENIC
    KUDER, P
    ABERGEL, A
    JOUANEL, P
    BONNY, C
    BRUN, H
    HENQUELL, C
    LAFEUILLE, H
    BOMMELAER, G
    HEPATOLOGY, 1995, 22 (04) : 1342 - 1342
  • [10] INTERFERON-ALPHA AND AUTOIMMUNITY
    PAPO, T
    PIETTE, JC
    DU, LTH
    GODEAU, P
    ANNALES DE MEDECINE INTERNE, 1993, 144 (05): : 357 - 366